Vibrotactile Feedback in Exoskeletons
The Effect of Vibrotactile Feedback on Exoskeleton Use in People With Motor Complete Spinal Cord Injury
2 other identifiers
interventional
7
1 country
1
Brief Summary
This study aims to investigate the impact of providing discrete vibrotactile feedback related to weight shift and step initiation on exoskeleton use in individuals with motor-complete SCI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 21, 2023
CompletedFirst Submitted
Initial submission to the registry
February 28, 2024
CompletedFirst Posted
Study publicly available on registry
March 12, 2024
CompletedMarch 12, 2024
March 1, 2024
4 months
February 28, 2024
March 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Walking distance covered
Walking distance covered during a 50-second walking trial.
Up to 3 weeks
Secondary Outcomes (4)
Reach path ratio
Up to 3 weeks
Reach time
Up to 3 weeks
User experience questionnaire
After 3 weeks
Dutch version of the Quebec User Evaluation of Satisfaction with Assistive Technology (D-QUEST) - only including the eight items related to user satisfaction with the assistive device
After 3 weeks
Other Outcomes (1)
Dutch System Usability Scale (D-SUS)
After 3 weeks
Study Arms (1)
Vibrotactile feedback
EXPERIMENTALParticipants will receive vibrotactile feedback in the ABLE Exoskeleton.
Interventions
The ABLE exoskeleton is accompanied by a vibrotactile feedback belt which users wear around their chest to receive real-time feedback during the double support phase. This feedback can assist them in their weight shift during the double support phase.
Eligibility Criteria
You may qualify if:
- SCI classification American Spinal Injury Association Impairment Scale (AIS) A or B
- Minimally six months post-injury
- Prior experience with the ReWalk Exoskeleton, able to walk independently
You may not qualify if:
- Pre-existing somatosensory problems before the SCI
- Visual or auditory issues that are not resolved with glasses or a hearing device
- Insufficient mastery of the Dutch language
- Contraindications related to the ABLE Exoskeleton
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sint Maartensklinieklead
- ABLE Human Motion S.L.collaborator
- Netherlands Organisation for Scientific Researchcollaborator
Study Sites (1)
Sint Maartenskliniek
Nijmegen, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Noël Keijsers
Sint Maartenskliniek
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 28, 2024
First Posted
March 12, 2024
Study Start
March 6, 2023
Primary Completion
June 21, 2023
Study Completion
June 21, 2023
Last Updated
March 12, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share